Company Filing History:
Years Active: 2002-2005
Title: Innovations of Anna-Maria Frischauf: A Pioneer in CD39-like Polypeptides
Introduction
Anna-Maria Frischauf is a remarkable inventor based in London, GB, known for her groundbreaking contributions to the field of biotechnology. With a total of 9 patents to her name, she has made significant strides in developing methods and compositions related to CD39-like polypeptides and nucleic acids. Her innovative work not only advances scientific understanding but also opens new avenues for therapeutic and diagnostic applications.
Latest Patents
Among her latest patents are two key inventions that explore the potential of CD39-like gene products. The inventions provide novel polynucleotides and proteins encoded by such polynucleotides. These discoveries come with therapeutic, diagnostic, and research utilities, showcasing the versatility and importance of her innovations. In particular, her work highlights the amino acid and nucleic acid sequences of the novel CD39-like gene and the associated gene products.
Career Highlights
Throughout her career, Anna-Maria has demonstrated an exceptional ability to innovate, leading to her recognition as a pioneering inventor in her domain. Her work has not only enriched her field but has also contributed to several research initiatives at well-regarded institutions.
Collaborations
Anna-Maria Frischauf has collaborated with notable professionals, including Brian Paul Chadwick. Together, they have worked across various projects, further advancing the understanding of CD39-like polypeptides.
Conclusion
In conclusion, Anna-Maria Frischauf's contributions to biotechnology through her innovative patents and collaborative efforts underscore her status as a leading inventor. Her work in the characterization of CD39-like polypeptides holds significant promise for the future of therapeutic and diagnostic advancements. The impact of her inventions continues to inspire those in the scientific community and beyond.